A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data

Diabetes Technology and Therapeutics

Volumn 17, Issue 8, 2015, Pages 555-562

  Wong, Jenise C ^a   Neinstein, Aaron B ^a   Spindler, Matthew ^a   Adi, Saleh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CAREGIVER; CHILD; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MEDICAL RECORD REVIEW; PATIENT ATTITUDE; PRIORITY JOURNAL; SELF REPORT; ADOLESCENT; AGE; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; INFORMATION RETRIEVAL; ODDS RATIO; PSYCHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CAREGIVERS; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH BEHAVIOR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFORMATION STORAGE AND RETRIEVAL; LOGISTIC MODELS; MALE; ODDS RATIO; YOUNG ADULT;

EID: 84938564215     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0413     Document Type: Article

References (32)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Nathan DM, Cleary PA, Backlund J-YC, et al.: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Nathan DM, Zinman B, Cleary PA, et al.: Modern-day clinical course of type 1 diabetesmellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983-2005). Arch Intern Med 2009;169:1307-1316.
4. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment for Normal Eating (DAFNE) randomised controlled trial. BMJ 2002;325:746.
5. Lowe J, Linjawi S, Mensch M, et al.: Flexible eating and flexible insulin dosing in patients with diabetes: results of an intensive self-management course. Diabetes Res Clin Pract 2008;80:439-443.
6. Franc S, Dardari D, Boucherie B, et al.: Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients. Diabetes Metab 2009; 35:463-468.
7. Amiel SA: Type 1 diabetes: treatment without tears? Diabetologia 2005;48:1963-1964.
8. Lawton J, Rankin D, Cooke D, et al.: Patients' experiences of adjusting insulin doses when implementing flexible intensive insulin therapy: a longitudinal, qualitative investigation. Diabetes Res Clin Pract 2012;98:236-242.
9. Shalitin S, Phillip M: The role of new technologies in treating children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2007;8(Suppl 6):72-79.
10. Rubin RR, Borgman SK, Sulik BT: Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy. Diabetes Educ 2011;37(Suppl 1):5S-18S; quiz 19S-20S.
11. Welsh JB, Myers SJ, Uhrinak AN, et al.: User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes. J Diabetes Sci Technol 2012;6:481-482.
12. Shalitin S, Ben-Ari T, Yackobovitch-Gavan M, et al.: Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol 2014;51:247-256.
13. American Diabetes Association: Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-S80.
14. Pihoker C, Forsander G, Fantahun B, et al.: The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes 2014;15(Suppl 20):86-101.
15. Meade LT, Rushton WE: Optimizing insulin pump therapy: a quality improvement project. Diabetes Educ 2013;39:841-847.
16. Nardacci EA, Bode BW, Hirsch IB: Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice. Diabetes Educ 2010;36(Suppl 1):4S-19S; quiz 20S-21S.
17. Bashan E, Herman WH, Hodish I: Are glucose readings sufficient to adjust insulin dosage? Diabetes Technol Ther 2011;13:85-92.
18. Bashan E, Hodish I: Frequent insulin dosage adjustments based on glucose readings alone are sufficient for a safe and effective therapy. J Diabetes Complications 2012;26:230-236.
19. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46:183-190.
20. Tanenberg R, Bode B, Lane W, et al.: Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-1526.
21. Mauras N, Fox L, Englert K, et al.: Continuous glucose monitoring in type 1 diabetes. Endocrine 2013;43:41-50.
22. Buckingham B, Xing D, Weinzimer S, et al.: Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes 2008; 9:142-147.
23. Wong JC, Foster NC, Maahs DM, et al.: Real-time continuous glucose monitoring among participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702-2709.
24. Corriveau EA, Durso PJ, Kaufman ED, et al.: Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:360-366.
25. Szymezak J, Leroy N, Lavalard E, et al.: Evaluation of the DCA Vantage analyzer for HbA 1c assay. Clin Chem Lab Med 2008;46:1195-1198.
26. Beck RW, Tamborlane WV, Bergenstal RM, et al.: The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97:4383-4389.
27. Peters A, Laffel L, American Diabetes Association Transitions Working Group: Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 2011;34:2477-2485.
28. Anderson B, Ho J, Brackett J, et al.: Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997;130:257-265.
29. King PS, Berg CA, Butner J, et al.: Longitudinal trajectories of parental involvement in Type 1 diabetes and adolescents' adherence. Health Psychol 2014;33:424-432.
30. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
31. Edwards AL: The Social Desirability Variable in Personality Assessment and Research. New York: Dryden, 1957.
32. Nunnally JC: Psychometric Theory, 2nd ed. New York: McGraw-Hill, 1978.